The ranking has been updated in its composition by 72%: 14 companies have moved from last year's list to this year's, including pharmaceutical company FC Grand Capital.
The ranking is based on the revenue trends of the applicants over the last three years. Accordingly, the revenue generated by the companies in the previous four years is taken into account.
Selected applicants from the SPARK (Professional Market and Company Analysis System) database and the RBC 500 ranking for 2021 who meet the following criteria
After the selection of applicants, a final score - the Growth Factor (GF) - was calculated for all the companies on the longlist.
Learn more on RBC:
https://trends.rbc.ru/trends/innovation/61c098129a79471217496cd1
On 9 December 2021, the pharmaceutical company Avexima JSC and Moscow Region Development Corporation JSC signed an additional agreement...